• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在培养的哺乳动物细胞中,扩展型聚谷氨酰胺结构域荧光融合蛋白的寡聚化。

Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cells.

作者信息

Onodera O, Burke J R, Miller S E, Hester S, Tsuji S, Roses A D, Strittmatter W J

机构信息

Department of Medicine (Neurology), Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Biochem Biophys Res Commun. 1997 Sep 18;238(2):599-605. doi: 10.1006/bbrc.1997.7337.

DOI:10.1006/bbrc.1997.7337
PMID:9299559
Abstract

Six inherited neurologic diseases, including Huntington's disease, result from the expansion of a CAG domain of the disease genes to produce a domain of more than 40 glutamines in the expressed protein. The mechanism by which expansion of this polyglutamine domain causes disease is unknown. Recent studies demonstrated oligomerization of polyglutamine-domain proteins in mammalian neurons. To study oligomerization of polyglutamine proteins and to identify heterologous protein interactions, varying length polyglutamine-green fluorescent protein fusion proteins were expressed in cultured COS-7 cells. The 19- and 35-glutamine fusion proteins (non-pathologic length) distributed diffusely throughout the cytoplasm. In contrast, 56- and 80-glutamine fusion proteins (pathologic length) formed fibrillar arrays resembling those previously observed in neurons in Huntington's disease and in a transgenic mouse model. These aggregates were intranuclear and intracytoplasmic. Intracytoplasmic aggregates were surrounded by collapsed intermediate filaments. The intermediate filament protein vimentin co-immunoisolated with expanded polyglutamine fusion proteins. This cellular model will expedite investigations into oligomerization of polyglutamine proteins and their interactions with other proteins.

摘要

包括亨廷顿舞蹈症在内的六种遗传性神经疾病,是由于疾病基因的CAG结构域发生扩增,从而在表达的蛋白质中产生一个含有超过40个谷氨酰胺的结构域所致。这种多聚谷氨酰胺结构域的扩增导致疾病的机制尚不清楚。最近的研究表明,多聚谷氨酰胺结构域蛋白在哺乳动物神经元中会发生寡聚化。为了研究多聚谷氨酰胺蛋白的寡聚化并鉴定异源蛋白相互作用,在培养的COS-7细胞中表达了不同长度的多聚谷氨酰胺-绿色荧光蛋白融合蛋白。含有19个和35个谷氨酰胺的融合蛋白(非致病长度)在整个细胞质中呈弥散分布。相比之下,含有56个和80个谷氨酰胺的融合蛋白(致病长度)形成了纤维状阵列,类似于先前在亨廷顿舞蹈症患者的神经元以及转基因小鼠模型中观察到的情况。这些聚集体存在于细胞核内和细胞质内。细胞质内的聚集体被塌陷的中间丝所包围。中间丝蛋白波形蛋白与扩增的多聚谷氨酰胺融合蛋白进行了共免疫分离。这个细胞模型将加快对多聚谷氨酰胺蛋白寡聚化及其与其他蛋白相互作用的研究。

相似文献

1
Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cells.在培养的哺乳动物细胞中,扩展型聚谷氨酰胺结构域荧光融合蛋白的寡聚化。
Biochem Biophys Res Commun. 1997 Sep 18;238(2):599-605. doi: 10.1006/bbrc.1997.7337.
2
Expanded polyglutamine domain proteins bind neurofilament and alter the neurofilament network.扩展的聚谷氨酰胺结构域蛋白与神经丝结合并改变神经丝网络。
Exp Neurol. 1999 Feb;155(2):195-203. doi: 10.1006/exnr.1998.6991.
3
The length of polyglutamine tract, its level of expression, the rate of degradation, and the transglutaminase activity influence the formation of intracellular aggregates.聚谷氨酰胺序列的长度、其表达水平、降解速率以及转谷氨酰胺酶活性会影响细胞内聚集体的形成。
Biochem Biophys Res Commun. 1999 Jun 24;260(1):150-8. doi: 10.1006/bbrc.1999.0851.
4
Intracellular green fluorescent protein-polyalanine aggregates are associated with cell death.细胞内绿色荧光蛋白 - 聚丙氨酸聚集体与细胞死亡有关。
Biochem J. 2000 May 15;348 Pt 1(Pt 1):15-9.
5
Proteasome degrades soluble expanded polyglutamine completely and efficiently.蛋白酶体能够完全且高效地降解可溶性的多聚谷氨酰胺扩增产物。
Neurobiol Dis. 2004 Jun;16(1):202-11. doi: 10.1016/j.nbd.2003.12.020.
6
Localization of active form of caspase-8 in mouse L929 cells induced by TNF treatment and polyglutamine aggregates.肿瘤坏死因子处理和多聚谷氨酰胺聚集体诱导的小鼠L929细胞中活性形式的半胱天冬酶-8的定位
Biochem Biophys Res Commun. 2000 Apr 21;270(3):972-7. doi: 10.1006/bbrc.2000.2463.
7
Effects of chain length on the aggregation of model polyglutamine peptides: molecular dynamics simulations.链长对模型聚谷氨酰胺肽聚集的影响:分子动力学模拟
Proteins. 2007 Jan 1;66(1):96-109. doi: 10.1002/prot.21132.
8
Properties of the nonhelical end domains of vimentin suggest a role in maintaining intermediate filament network structure.波形蛋白非螺旋末端结构域的特性表明其在维持中间丝网络结构中发挥作用。
J Struct Biol. 2000 Nov;132(2):83-94. doi: 10.1006/jsbi.2000.4315.
9
Solubilization of aggregates formed by expanded polyglutamine tract expression in cultured cells.培养细胞中由扩展的聚谷氨酰胺序列表达形成的聚集体的溶解。
Methods Mol Biol. 2004;277:129-37. doi: 10.1385/1-59259-804-8:129.
10
Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening.通过噬菌体展示筛选鉴定的新型肽对多聚谷氨酰胺蛋白聚集和细胞死亡的抑制作用
J Biol Chem. 2000 Apr 7;275(14):10437-42. doi: 10.1074/jbc.275.14.10437.

引用本文的文献

1
Lack of Hikeshi activates HSF1 activity under normal conditions and disturbs the heat-shock response.缺乏 Hikeshi 在正常情况下会激活 HSF1 的活性,并扰乱热休克反应。
Life Sci Alliance. 2022 May 17;5(9). doi: 10.26508/lsa.202101241. Print 2022 Sep.
2
C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside.Hsp70 相互作用蛋白(CHIP)的 C 末端与神经退行性变:来自实验室和临床的经验教训。
Curr Neuropharmacol. 2021;19(7):1038-1068. doi: 10.2174/1570159X18666201116145507.
3
Aggresome-Like Formation Promotes Resistance to Proteotoxicity in Cells from Long-Lived Species.
聚集物样形成促进长寿物种细胞对抗蛋白毒性。
J Gerontol A Biol Sci Med Sci. 2020 Jul 13;75(8):1439-1447. doi: 10.1093/gerona/glaa069.
4
Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.亨廷顿舞蹈症中的糖基化:一种可能的修饰因素及干预靶点
J Huntingtons Dis. 2019;8(3):245-256. doi: 10.3233/JHD-190366.
5
Polyglutamine Repeats in Viruses.病毒中的多聚谷氨酰胺重复序列。
Mol Neurobiol. 2019 May;56(5):3664-3675. doi: 10.1007/s12035-018-1269-4. Epub 2018 Sep 4.
6
Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases.蛋白质错误折叠与聚集作为聚谷氨酰胺疾病的治疗靶点
Brain Sci. 2017 Oct 11;7(10):128. doi: 10.3390/brainsci7100128.
7
Polyglutamine tracts regulate beclin 1-dependent autophagy.聚谷氨酰胺序列调节依赖于贝林1的自噬。
Nature. 2017 May 4;545(7652):108-111. doi: 10.1038/nature22078. Epub 2017 Apr 26.
8
siRNA screen identifies QPCT as a druggable target for Huntington's disease.siRNA 筛选鉴定 QPCT 为亨廷顿病的可用药靶标。
Nat Chem Biol. 2015 May;11(5):347-354. doi: 10.1038/nchembio.1790. Epub 2015 Apr 6.
9
Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell.错误折叠的多聚谷氨酰胺、多聚丙氨酸和超氧化物歧化酶 1 通过细胞中的不同途径聚集。
J Biol Chem. 2014 Mar 7;289(10):6669-6680. doi: 10.1074/jbc.M113.520189. Epub 2014 Jan 14.
10
The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases.聚集抑制剂肽QBP1作为聚谷氨酰胺神经退行性疾病的治疗分子
J Amino Acids. 2011;2011:265084. doi: 10.4061/2011/265084. Epub 2011 Jun 30.